Krystyna Houser Honored with 2025 Innovation Award from Crohn’s & Colitis Foundation
The patient-founder of mBIOTA Labs is recognized for her dedication to developing physician-trusted solutions for the patient community
Santa Monica – October 11, 2025 – mBIOTA Labs, an emerging medical food company revolutionizing medical nutrition for the management of gastrointestinal (GI) conditions, is pleased to announce that its patient-founder, Krystyna Houser, has today been honored with the 2025 Innovation Award from the Crohn’s & Colitis Foundation Greater Los Angeles/Orange County Chapter during its Imagine the Cure Gala.
The Innovation Award recognizes Houser for her development of the first palatable elemental diet designed to support patients struggling with gut health disorders, including Crohn’s disease and colitis. Inspired by her own GI patient journey, Houser is dedicated to bringing innovative, science-backed, and physician-trusted solutions to the patient community. Houser created mBIOTA Labs to transform therapeutic nutrition through science, empathy, and action by creating research-driven solutions for the dietary management of gastrointestinal disorders affecting nearly 40% of Americans.
“I am so grateful to the Crohn’s & Colitis Foundation for this honor,” says Krystyna Houser, founder of mBIOTA Labs. “It can be hard to describe to those without GI conditions how thoroughly they can affect your life. The scientific community is still uncovering new insights every day about the gastrointestinal system and how GI conditions impact the rest of the body. My team and I are proud to have developed a physician-trusted solution that resonates with so many patients and is making a real difference.”
Earlier this year, Houser was named to the Inc. Female Founders 500 list for her fierce advocacy on behalf of patients with GI dysfunction and embodiment of mBIOTA’s mission to support patients with chronic GI conditions. She has been a leader in raising awareness of palatable elemental diets as a medical nutrition protocol that stands to improve millions of lives.
mBIOTA Labs launched its flagship product, mBIOTA Elemental Diet, in January 2024. It is a nutrition-based and clinically proven option that is inherently non-inflammatory, and is available directly to consumers to manage their GI disorders without struggling through traditional elemental diets or less effective antibiotics and pharmaceuticals. To date, mBIOTA has supported several thousands of patients across the U.S. and 39 countries internationally, with a vision to expand further into yet unserved patient communities. To learn more about the company, visit mbiota.com.
About mBIOTA Labs
mBIOTA Labs empowers individuals with evidence-based nutrition solutions that enhance quality of life. Trusted by the medical community, mBIOTA Labs harnesses proprietary Amino Taste Modification Technology (ATMT) to create science-backed medical foods designed to support individuals with a wide range of digestive issues. mBIOTA's award-winning, clinically proven, palatable elemental diet, mBIOTA Elemental™, revolutionizes medical nutrition for the dietary management of GI dysfunction, including small intestinal bacterial overgrowth (SIBO), intestinal methanogen overgrowth (IMO), irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD) such as Crohn’s disease and colitis, eosinophilic esophagitis (EoE), and other conditions. mBIOTA is actively investigating and researching expanded applications of the elemental diet to aid and provide solutions to more patients. Learn more about mBIOTA Labs and published research supporting mBIOTA Elemental Diet by visiting www.mBIOTA.com.
